Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Clinical trial NCT06459687 · RECRUITING
Trial details
- NCT number
- NCT06459687
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-28
- Primary completion
- 2027-09-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.